tiprankstipranks
Advertisement
Advertisement

ONCY Stock Latest News

Oncolytics promotes John McAdory to COO
The FlyOncolytics promotes John McAdory to COO
2d ago
CGON
ONCY
Oncolytics Biotech Strengthens Leadership with New COO, Director
PremiumCompany Announcements
Oncolytics Biotech Strengthens Leadership with New COO, Director
2d ago
8K
ONCY
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
PremiumCompany Announcements
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
3d ago
8K
ONCY
Oncolytics announces initial data from pelareorep combination study
PremiumThe Fly
Oncolytics announces initial data from pelareorep combination study
3d ago
ONCY
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
PremiumThe Fly
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
13d ago
ONCY
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
PremiumCompany AnnouncementsOncolytics Highlights Pelareorep Immune Activation Data at ASCO
13d ago
8K
ONCY
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
Premium
Ratings
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
14d ago
ONCY
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
Premium
Company Announcements
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
1M ago
8K
ONCY
Oncolytics says in alignment with FDA following pelareorep Type C meeting
PremiumThe Fly
Oncolytics says in alignment with FDA following pelareorep Type C meeting
1M ago
ONCY
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
PremiumCompany Announcements
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
1M ago
8K
ONCY
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
PremiumRatings
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
2M ago
ONCY
Oncolytics price target lowered to $5 from $7 at Lake Street
PremiumThe Fly
Oncolytics price target lowered to $5 from $7 at Lake Street
2M ago
ONCY
Oncolytics Biotech Establishes $75 Million ATM Offering
PremiumCompany AnnouncementsOncolytics Biotech Establishes $75 Million ATM Offering
2M ago
8K
ONCY
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
Premium
Company Announcements
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
2M ago
8K
ONCY
Oncolytics schedules FDA meeting for pelareorep registrational path
Premium
The Fly
Oncolytics schedules FDA meeting for pelareorep registrational path
2M ago
ONCY
Oncolytics Biotech Completes Domestication to Nevada with New Governance
PremiumCompany Announcements
Oncolytics Biotech Completes Domestication to Nevada with New Governance
2M ago
8K
ONCY
Oncolytics completes domicile change to the U.S.
PremiumThe Fly
Oncolytics completes domicile change to the U.S.
2M ago
ONCY
Oncolytics files $250M mixed securities shelf
PremiumThe Fly
Oncolytics files $250M mixed securities shelf
2M ago
ONCY
Oncolytics Biotech Shifts Corporate Domicile to British Columbia
PremiumCompany Announcements
Oncolytics Biotech Shifts Corporate Domicile to British Columbia
3M ago
8K
ONCY
Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
PremiumCompany AnnouncementsOncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
3M ago
ONCY
Oncolytics Highlights New Pelareorep Data in Cancer Immunotherapy
Premium
Company Announcements
Oncolytics Highlights New Pelareorep Data in Cancer Immunotherapy
3M ago
8K
ONCY
Oncolytics to present new data on Pelareorep at AACR 2026
Premium
The Fly
Oncolytics to present new data on Pelareorep at AACR 2026
3M ago
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >